Login / Signup

Tranexamic acid for percutaneous nephrolithotomy: an abridged Cochrane Review.

Brent ClevelandBrett NorlingHill WangVardhil GandhiCarrie L PriceMichael BorofskyVernon PaisPhilippe D Violette
Published in: BJU international (2023)
Based on a body of evidence of 10 RCTs, we found that systemic TXA in PCNL may reduce blood transfusions, major surgical complications, and hospital LOS, as well as improve SFR; however, it may increase AE. These findings should inform urologists and their patients in making informed decisions about the use of TXA in the setting of PCNL.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • healthcare
  • peritoneal dialysis
  • prognostic factors
  • risk factors
  • minimally invasive
  • emergency department
  • radiofrequency ablation